Axon Enterprise, Inc $AXON Shares Sold by Edgewood Management LLC

Axon Enterprise logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Edgewood Management cut its Axon stake by 35%, selling 393,384 shares in the third quarter. It retained 731,291 shares, valued at about $309 million and representing 4.9% of its portfolio.
  • Analysts have a “Moderate Buy” consensus, with a consensus price target of $612.18; 13 analysts rate the stock Buy and four rate it Hold.
  • Axon’s latest quarterly results missed estimates: earnings were $1.72 per share versus $1.89 expected, and revenue was $908.55 million versus $934.33 million expected. Revenue nevertheless rose 27.8% year over year.
  • Five stocks to consider instead of Axon Enterprise.

Edgewood Management LLC lessened its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 35.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 731,291 shares of the biotechnology company's stock after selling 393,384 shares during the quarter. Axon Enterprise accounts for approximately 4.9% of Edgewood Management LLC's portfolio, making the stock its 7th biggest position. Edgewood Management LLC owned approximately 0.90% of Axon Enterprise worth $308,985,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the company. State Street Corp increased its holdings in Axon Enterprise by 5,700.2% in the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company's stock valued at $119,724,905,000 after buying an additional 209,879,882 shares during the last quarter. Envestnet Asset Management Inc. raised its position in shares of Axon Enterprise by 18,050.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company's stock worth $7,400,094,000 after acquiring an additional 13,127,348 shares in the last quarter. BlackRock Inc. raised its position in shares of Axon Enterprise by 4.3% during the 2nd quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company's stock worth $4,672,432,000 after acquiring an additional 345,365 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in Axon Enterprise by 391,214.9% during the third quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company's stock worth $2,952,943,000 after purchasing an additional 6,987,098 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in Axon Enterprise by 5,022.8% during the third quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company's stock worth $1,802,719,000 after purchasing an additional 4,183,302 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have commented on AXON. Northland Securities set a $540.00 price target on shares of Axon Enterprise in a research note on Friday, November 6th. Morgan Stanley increased their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an "overweight" rating in a research report on Thursday, August 6th. UBS Group lifted their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a "neutral" rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. reduced their price target on shares of Axon Enterprise from $755.00 to $610.00 and set an "overweight" rating for the company in a research report on Friday, November 6th. Finally, Needham & Company LLC dropped their price objective on Axon Enterprise from $750.00 to $500.00 and set a "buy" rating on the stock in a report on Friday, November 6th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Axon Enterprise has a consensus rating of "Moderate Buy" and a consensus price target of $612.18.

Check Out Our Latest Stock Report on AXON

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $291.13 on Friday. The firm's fifty day simple moving average is $398.48 and its 200-day simple moving average is $462.93. Axon Enterprise, Inc has a 12 month low of $289.68 and a 12 month high of $665.07. The stock has a market capitalization of $23.71 billion, a price-to-earnings ratio of 93.31, a PEG ratio of 5.82 and a beta of 1.48. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Friday, November 6th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts' consensus estimates of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The business had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same quarter in the prior year, the firm posted $1.17 earnings per share. The company's revenue for the quarter was up 27.8% compared to the same quarter last year. As a group, equities analysts forecast that Axon Enterprise, Inc will post 1.65 earnings per share for the current year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 16,775 shares of the company's stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president directly owned 296,974 shares of the company's stock, valued at $170,590,774.82. This represents a 5.35% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the sale, the insider directly owned 56,264 shares of the company's stock, valued at $27,032,038.80. The trade was a 1.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 27,792 shares of company stock worth $15,214,581 in the last quarter. Company insiders own 4.20% of the company's stock.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Featured Articles

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines